Methylene Chloride Reaction Solvent

Interfacial Polycarbonate Trains and the DCM-Set Viscosity Ceiling

In the interfacial polycarbonate train, dichloromethane (DCM) is charged as the continuous organic phase into which phosgene is introduced as a gas or as a 10–20 wt% solution, while bisphenol A is maintained as the sodium salt in an aqueous caustic phase containing 25–40 wt% sodium hydroxide. The solvent-to-bisphenol A mass ratio is adjusted within 4:1 to 8:1, holding organic-phase solids at 12–18 wt%; phosgene is supplied at 1.05–1.20 molar equivalents, p-cumylphenol chain stopper at 2.0–4.0 mol% of bisphenol A, and triethylamine catalyst at 0.1–0.5 mol%. Polymerization is run at 20–35°C with automated caustic feed controlling interfacial pH between 9.5 and 10.8. Because DCM boils at 39.6°C at atmospheric pressure, the jacketed stirred tank is fitted with a reflux condenser sized for the polycondensation exotherm, and high-shear rotor-stator recirculation maintains interfacial area without emulsifying the organic phase. If pH drifts above 10.8, carbonate hydrolysis accelerates and the organic layer develops clouding within 15–30 min; if pH falls below 9.5, chain extension slows and gel-permeation chromatography of the isolated resin shows broadened or bimodal molecular weight distribution. When a target weight-average molecular weight of 30,000–70,000 g/mol is required, additional DCM is introduced when agitator amp draw or positive-displacement pump discharge pressure indicates organic-phase viscosity approaching equipment-dependent limits; this solvent dilution prevents shear-induced chain scission and poor downstream antisolvent precipitation. Polycarbonate resin produced by this route is steam-precipitated, dried, and melt-compounded with heat stabilizers before pelletizing. Terminal product types include optical discs, automotive headlamp lenses and glazing, electronic equipment housings, and medical device components. Compliance documentation for food-contact grades is evaluated against FDA 21 CFR 177.1580 and EU 10/2011; medical-grade resins are screened according to ISO 10993-1:2018. REACH Annex XVII entry 59 restricts DCM in paint strippers but does not govern closed reaction-solvent use, although site workplace exposure and emission permits remain applicable.

Quaternization of alkyldimethylamines with benzyl chloride in DCM is conducted as a pressurized batch reaction because the desired alkylation rate requires 60–80°C, above the solvent boiling point of 39.6°C. A glass-lined or Hastelloy C-22 reactor rated to 2–4 barg is charged with 0.8–2.0 parts by weight of DCM per part of tertiary amine, resulting in a reaction-mass solids content of 35–55 wt% after conversion. Sodium carbonate or sodium hydroxide is optionally added at 0.2–1.0 wt% to bind hydrogen chloride released from benzyl chloride hydrolysis. Benzyl chloride is metered beneath the liquid surface over 2–4 h, while the jacket is held at 70–80°C and inerting prevents moisture ingress that would hydrolyze the alkylating agent. Reaction endpoint is determined by amine value according to ASTM D2074-07; residual tertiary amine is reduced below 0.5 meq/g. Vacuum stripping at 60°C and 20–50 mbar reduces residual DCM to 600 ppm or lower, consistent with ICH Q3C(R8) where pharmaceutical-grade quaternary ammonium intermediates are involved. For disinfectant active substances, technical concentrates require solvent residue data under EU BPR 528/2012 or EPA FIFRA 40 CFR 158.500. Terminal product types include benzalkonium chloride and dialkyldimethylammonium chloride concentrates for hard-surface disinfectants, industrial water-treatment microbicides, and swimming-pool algaecides.

How Does Aluminum Chloride Charge Affect Solvent Retention in DCM-Solvated Friedel-Crafts Acylations?

In Friedel-Crafts acylations run in DCM, the solvent is loaded at 5–10 L per kg of aromatic substrate to suspend aluminum chloride and absorb the acylation exotherm. The acyl chloride is added at 1.05–1.5 molar equivalents relative to substrate, while aluminum chloride is charged at 2.0–3.0 molar equivalents because the ketone product consumes one equivalent as an acid–base complex and additional Lewis acid is required for acylium ion generation. The reaction is held at 0–15°C under brine cooling, and the acyl chloride feed is extended over 1–3 h to avoid temperature excursions that cause evaporative DCM loss and concentration drift. A glass-lined reactor equipped with a reflux condenser, anhydrous hydrochloric acid scrubber, and slow-speed anchor agitator is used. The quench is performed by transferring the reaction mass into ice-water at 0–5°C to decompose the aluminum chloride–ketone complex; the organic phase is then separated, washed with dilute hydrochloric acid and sodium bicarbonate, and distilled at 38–40°C for solvent recovery. The operational boundary is the boiling point of DCM, not Lewis-base interaction with the catalyst. For pharmaceutical intermediates, ICH Q7 GMP and ICH Q3C(R8) residual solvent limits apply; general industrial output is covered by REACH (EC 1907/2006) exposure scenarios and site VOC abatement permits. Terminal product types include substituted benzophenones used as UV-curable photoinitiators, pharmaceutical intermediates, and specialty monomers for high-refractive-index polymers.

Depending on bead crosslink density, DCM serves simultaneously as a swelling penetrant and heat-sink solvent in the chloromethylation of styrene–divinylbenzene beads containing 2–8 wt% divinylbenzene. The swollen-bead solvent uptake is adjusted to 3–5 mL/g of dry polymer, zinc chloride or ferric chloride is charged at 0.4–0.8 mol per mole of chloromethyl methyl ether, and the reaction is held at 35–45°C for 4–8 h in a jacketed reactor with a double mechanical seal and a caustic scrubber for chloromethyl methyl ether. Published plant-scale data for this specific configuration is limited outside equipment-vendor filings; the stated ranges represent common batch practice rather than a universal window. The degree of chloromethylation is followed by chloride content after hydrolysis. When the target anion-exchange capacity is 1.0–1.4 eq/L in the chloride form, the chloromethylated intermediate is aminated with trimethylamine in aqueous methanol at 30–50°C. The resulting strong-base anion-exchange resins comply with NSF/ANSI 61 where potable water contact is intended. Terminal product types include demineralization trains for boiler feedwater, pharmaceutical purification columns, and semiconductor ultrapure water polishing beds.

When Dichloromethane Doubles as Carbene Source and Heat Sink in Gem-Dichlorocyclopropane Trains

For the synthesis of gem-dichlorocyclopropane intermediates from terminal alkenes, DCM is both solvent and stoichiometric dichlorocarbene source in a two-phase reaction with 50 wt% aqueous sodium hydroxide. The alkene concentration is maintained between 0.5 M and 1.5 M in the DCM phase, caustic is charged at 5–10 molar equivalents, and benzyltriethylammonium chloride is added at 0.5–2.0 mol% relative to the alkene. A glass-lined vessel with a reflux condenser rated for 39.6°C vapor and a brine jacket held at 20–30°C is used; caustic is metered over 2–6 h because deprotonation of the solvent and subsequent carbene addition is strongly exothermic. Conversion is monitored by gas chromatography with flame ionization detection, and the batch is taken to endpoint when the terminal alkene peak falls below 0.5 area%. The organic layer is separated, washed with dilute hydrochloric acid, dried, and distilled at 38–40°C for solvent recovery. Residual DCM after distillation must meet ICH Q3C(R8) at 600 ppm for pharmaceutical intermediates, or the registration-specific limit for pesticide active substances under EU BPR 528/2012 or FAO specifications. Aqueous-phase carryover promotes hydrolysis of the dichlorocyclopropane toward chlorinated ketones, making interface control and slow quench critical. Terminal product types include gem-dichlorocyclopropane carboxylic acid derivatives used in pyrethroid insecticide active ingredients and constrained cyclopropane building blocks for agrochemical and pharmaceutical synthesis.

Allylic Bromination with N-Bromosuccinimide: Boiling Point as the Kinetic Ceiling

Allylic bromination of substituted alkenes in DCM is run at the solvent reflux temperature of 39.6°C, which fixes the upper reaction temperature and therefore the half-life of the radical initiator. Azobisisobutyronitrile is dosed at 0.5–2.0 mol% relative to the alkene, N-bromosuccinimide is added at 1.0–1.2 molar equivalents, and the solvent volume is adjusted to 10–15 L per kg of substrate to prevent the succinimide by-product from forming a paste that stalls agitator torque. A glass-lined reactor with a nitrogen purge and a peroxide-checked condenser is used because the combination of radical initiator and chlorinated solvent requires strict inerting to suppress oxygen-fed side reactions. The slurry is filtered at 20–25°C, the filtrate is washed with aqueous thiosulfate to remove bromine color, and the solvent is recovered by distillation at 38–40°C. Residual DCM in the allylic bromide intermediate is reduced to 600 ppm under ICH Q3C(R8) where pharmaceutical or agrochemical registered intermediates are manufactured. General operations are controlled under REACH (EC 1907/2006) exposure scenarios and site VOC permits. Terminal product types include allylic bromide building blocks for sesquiterpene total synthesis, insect pheromone intermediates, and central nervous system drug candidate intermediates.